384 Dupilumab provides early and sustained,...

The Journal of Investigative Dermatology 2020 / 07 Vol. 140; Iss. 7

384 Dupilumab provides early and sustained, clinically-meaningful improvements in both adults and adolescents: A post hoc analysis of patients not achieving Investigator’s Global Assessment of 0/1 in phase 3 trials, LIBERTY AD SOLO 1 and 2, and LIBERTY AD ADOL

Simpson, E., Beck, L.A., Boguniewicz, M., Chen, Z., Ardeleanu, M., Bansal, A., Sierka, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
140
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2020.03.392
Date:
July, 2020
File:
PDF, 198 KB
2020
Conversion to is in progress
Conversion to is failed